A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders

Last updated: August 21, 2024
Sponsor: Charite University, Berlin, Germany
Overall Status: Active - Recruiting

Phase

N/A

Condition

Anxiety Disorders

Social Phobia

Agoraphobia (Fear Of Crowds)

Treatment

Velibra

Clinical Study ID

NCT04793828
EA 1/322/19
  • Ages 18-65
  • All Genders

Study Summary

The project's aim is to investigate the effect of a transdiagnostic, self-guided, internet-based cognitive behavioral therapy program in waitlist patients with anxiety disorders.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of panic disorder with or without agoraphobia, social anxiety disorder, orgeneralized anxiety disorder

  • Knowledge of German that is sufficient for engaging with the treatment andresponding to the questionnaires

  • Written informed consent

  • Internet access

Exclusion

Exclusion Criteria:

  • Diagnoses of severe mental comorbidities (e.g., schizophrenia, severe majordepression, borderline personality disorder)

  • Acute suicidality

  • Started or changed anxiolytic pharmacotherapy recently (currently or in the pastfour weeks)

Study Design

Total Participants: 30
Treatment Group(s): 1
Primary Treatment: Velibra
Phase:
Study Start date:
July 04, 2020
Estimated Completion Date:
December 31, 2025

Study Description

Patients who fulfill the inclusion criteria and are interested in psychotherapy are offered participation in the study to bridge the waiting time for face-to-face psychotherapy. After obtaining informed consent, a pre-treatment assessment is conducted. Then, participants are provided access to velibra, an internet-based cognitive behavioral therapy program which they can work through at their own pace. While velibra is a self-guided program, participants are supported by study personnel during four assessments at four time points: pre-treatment, mid-treatment (after the first three velibra modules), post-treatment and at the one-month follow-up. The investigators expect improvements on the primary as well as the secondary outcomes. Furthermore, the investigators are interested in studying the acceptability of velibra and whether positive changes already become observable after the first three modules, i.e., at the mid-treatment assessment.

Connect with a study center

  • Department of Psychiatry and Psychotherapy, Charité Campus Mitte - Universitätsmedizin Berlin

    Berlin, 10117
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.